Share Facebook Twitter Pinterest Email Copy Link Investors seem to be having second thoughts about the lofty valuations in the sector, an analyst said. Source link
Markets This disease is more expensive than cancer and heart disease combined. And it’s only going to get worse.June 26, 2026
Markets Why a reported delay for OpenAI’s listing complicates further the picture for tech stocksJune 26, 2026
